Gemcitabine
Lack of Assurance of Sterility
18,003 recalls, newest first
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.
CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.
CGMP Deviations: manufacturer recalled after an FDA inspection noted that these products were not manufactured under Current Good Manufacturing Practices.
Marketed Without an Approved NDA/ANDA: Product labeled to contain methanol making it an unapproved new drug and contains methanol
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Subpotent Drug: Product contains less Sodium Fluoride than listed on product label.
Labeling: Missing Label
Labeling: Missing Label
Presence of Particulate Matter: investigation into a customer complaint confirmed the presence of glass particulates.
Lack of Processing Controls